TrialPharmacogenetics and genomics2008

Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study.

Anke-Hilse Maitland-van der Zee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.